AR247762A1 - Un metodo para la preparacion de derivados de furo /3, 4-c/piridina en forma no-racemica - Google Patents
Un metodo para la preparacion de derivados de furo /3, 4-c/piridina en forma no-racemicaInfo
- Publication number
- AR247762A1 AR247762A1 AR91319663A AR31966391A AR247762A1 AR 247762 A1 AR247762 A1 AR 247762A1 AR 91319663 A AR91319663 A AR 91319663A AR 31966391 A AR31966391 A AR 31966391A AR 247762 A1 AR247762 A1 AR 247762A1
- Authority
- AR
- Argentina
- Prior art keywords
- yes
- compound
- preparation
- racemic
- pyridine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
METODO PARA PREPARAR, EN UN FORMA NO RACEMICA, DERIVADOS DE FURO ¡3, 4-C¿ PIRIDINA DE FORMULA I Y SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO, DONDE -R3 Y R'3, SON HIDROGENO; ALQUILO; HETEROCICLICO DE 5 MIEMBROS; O FENILO SUSTITUIDO POR HALOGENO; Y -R6 ES ALQUILO; RESOLVIENDO UNA MEZCLA RACEMICA DEL COMPUESTO DE FORMULA (4), DONDE A1 Y A2 ESTAN UNIDOS ENTRE SI Y A1-A2 SI -C(CH3)2-O- Y A3 ES R7, O A1 ES R7 Y A2 Y A3 ESTAN UNIDOS ENTRE SI Y A2- A3 ES UNA LIGADURA; Y R7 ES ACILO, SOMETIENDO EL COMPUESTO A LA ACCION DE UNA ESTERASA CAPAZ DE HIDROLIZAR LA FORMA ENANTIOMERICA (+) O (-) DE DICHO COMPUESTO, Y LUEGO SEPARAR LOS COMPUESTOS NO HIDROLIZADOS Y LOS HIDROLIZADOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/523,238 US5130252A (en) | 1990-05-14 | 1990-05-14 | Resolution of furopyridine enantiomers and synthetic precursors thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AR247762A1 true AR247762A1 (es) | 1995-03-31 |
Family
ID=24084213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR91319663A AR247762A1 (es) | 1990-05-14 | 1991-05-10 | Un metodo para la preparacion de derivados de furo /3, 4-c/piridina en forma no-racemica |
Country Status (32)
Country | Link |
---|---|
US (1) | US5130252A (es) |
JP (1) | JPH05117277A (es) |
KR (1) | KR910020015A (es) |
AR (1) | AR247762A1 (es) |
AT (1) | AT400445B (es) |
AU (1) | AU642368B2 (es) |
BE (1) | BE1007016A3 (es) |
CA (1) | CA2042421C (es) |
CH (1) | CH682488A5 (es) |
DE (1) | DE4115681C2 (es) |
DK (1) | DK88991A (es) |
DZ (1) | DZ1499A1 (es) |
ES (1) | ES2033574B1 (es) |
FI (1) | FI97807C (es) |
FR (1) | FR2661919B1 (es) |
GB (1) | GB2244056B (es) |
GR (1) | GR1001593B (es) |
HK (1) | HK131993A (es) |
IE (1) | IE65891B1 (es) |
IT (1) | IT1248743B (es) |
LU (1) | LU87935A1 (es) |
MA (1) | MA22154A1 (es) |
MY (1) | MY107567A (es) |
NL (1) | NL194615C (es) |
NO (1) | NO180308C (es) |
NZ (1) | NZ238009A (es) |
OA (1) | OA09352A (es) |
PT (1) | PT97657B (es) |
SE (1) | SE510808C2 (es) |
TN (1) | TNSN91035A1 (es) |
TW (1) | TW226998B (es) |
ZA (1) | ZA913461B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0221494D0 (en) * | 2002-09-16 | 2002-10-23 | Generics Uk Ltd | Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives |
US20110251396A1 (en) * | 2003-07-17 | 2011-10-13 | Gilead Sciences, Inc. | Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
US20060089374A1 (en) * | 2003-07-17 | 2006-04-27 | Glenn Cornett | Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
WO2005009446A1 (en) * | 2003-07-17 | 2005-02-03 | Cotherix, Inc. | Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome |
GB2423927A (en) * | 2003-08-29 | 2006-09-13 | Cotherix Inc | Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome |
US20060154959A1 (en) * | 2005-01-13 | 2006-07-13 | Navitas Pharma | Combination therapies of cicletanine and carvedilol |
US7375112B2 (en) * | 2005-01-05 | 2008-05-20 | Medicure International Inc. | Compounds and methods for regulating triglyceride levels |
US20070141174A1 (en) * | 2005-01-13 | 2007-06-21 | Navitas Pharma, Inc. | Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension |
US20080096915A1 (en) * | 2005-01-13 | 2008-04-24 | Greenberg Traurig LLP | Compositions for the treatment of metabolic disorders |
US20070105817A1 (en) * | 2005-11-09 | 2007-05-10 | Jim Page | Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension |
CA2674367A1 (en) * | 2007-01-03 | 2008-07-17 | Glenn V. Cornett | Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders |
EP2498605B1 (en) * | 2009-10-29 | 2014-08-27 | Merck Sharp & Dohme Corp. | Diuretics |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN156817B (es) * | 1981-02-10 | 1985-11-09 | Scras | |
US4985365A (en) * | 1981-11-28 | 1991-01-15 | Sumitomo Chemical Company, Ltd. | Process for producing optically active benzyl alcohol compound |
DE3378834D1 (en) * | 1982-08-13 | 1989-02-09 | Kanegafuchi Chemical Ind | Process for production of optically active oxazolidinone derivative |
IN160104B (es) * | 1983-04-05 | 1987-06-27 | Scras | |
JPS59216590A (ja) * | 1983-05-24 | 1984-12-06 | Ube Ind Ltd | 光学活性フエニルプロパルギルアルコ−ル誘導体の製法 |
GB8327817D0 (en) * | 1983-10-18 | 1983-11-16 | Scras | 4-halo-furo-(3 4-c)-pyridine derivatives |
GB8330517D0 (en) * | 1983-11-16 | 1983-12-21 | Scras | 6-vinyl-furo-(3,4-c)pyridine derivatives |
GB8330658D0 (en) * | 1983-11-17 | 1983-12-29 | Scras | 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives |
GB8402740D0 (en) * | 1984-02-02 | 1984-03-07 | Scras | Furo-(3 4-c)-pyridine derivatives |
JPS60224494A (ja) * | 1984-04-24 | 1985-11-08 | Nissan Chem Ind Ltd | α−メチルベンジルアルコ−ル類の光学分割法 |
GB8414559D0 (en) * | 1984-06-07 | 1984-07-11 | Scras | Pyridine derivatives |
GB8427218D0 (en) * | 1984-10-27 | 1984-12-05 | Scras | Pyridine derivatives |
JPS61289899A (ja) * | 1985-06-18 | 1986-12-19 | Kanegafuchi Chem Ind Co Ltd | 光学活性2−ハロ−1−フエニルエタノ−ルおよびそのエステルの製造法 |
US4916074A (en) * | 1986-10-30 | 1990-04-10 | Chisso Corporation | Process for producing optically active compounds |
JP2691986B2 (ja) * | 1987-08-28 | 1997-12-17 | チッソ株式会社 | ピリジン骨格を有する光学活性化合物の製造法 |
DE3737335A1 (de) * | 1987-11-04 | 1989-05-18 | Basf Ag | Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung |
GB8808001D0 (en) * | 1988-04-06 | 1988-05-05 | Scras | Stereospecific preparative process for furol(3,4-c)pyridine derivatives |
DE3990349T1 (de) * | 1988-04-06 | 1990-04-26 | Scras | Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen |
NL8801311A (nl) * | 1988-05-20 | 1989-12-18 | Stamicarbon | Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem. |
GB8907480D0 (en) * | 1989-04-03 | 1989-05-17 | Scaras Societe De Conseils De | Separation of insomers of furo(3,4-c)pyridine derivatives |
GB8917168D0 (en) * | 1989-07-27 | 1989-09-13 | Scras | Asymmetric synthesis of furo(3,4-c)pyridine derivatives |
-
1990
- 1990-05-14 US US07/523,238 patent/US5130252A/en not_active Expired - Lifetime
-
1991
- 1991-04-24 GR GR910100180A patent/GR1001593B/el not_active IP Right Cessation
- 1991-04-29 AU AU76200/91A patent/AU642368B2/en not_active Ceased
- 1991-05-01 NL NL9100749A patent/NL194615C/nl not_active IP Right Cessation
- 1991-05-01 NZ NZ238009A patent/NZ238009A/en unknown
- 1991-05-02 CH CH1318/91A patent/CH682488A5/fr not_active IP Right Cessation
- 1991-05-07 ZA ZA913461A patent/ZA913461B/xx unknown
- 1991-05-07 GB GB9109810A patent/GB2244056B/en not_active Expired - Fee Related
- 1991-05-08 MY MYPI91000775A patent/MY107567A/en unknown
- 1991-05-08 DZ DZ910055A patent/DZ1499A1/fr active
- 1991-05-08 IT ITMI911255A patent/IT1248743B/it active IP Right Grant
- 1991-05-10 AR AR91319663A patent/AR247762A1/es active
- 1991-05-13 TN TNTNSN91035A patent/TNSN91035A1/fr unknown
- 1991-05-13 CA CA002042421A patent/CA2042421C/en not_active Expired - Fee Related
- 1991-05-13 KR KR1019910007684A patent/KR910020015A/ko not_active Application Discontinuation
- 1991-05-13 AT AT0098291A patent/AT400445B/de not_active IP Right Cessation
- 1991-05-13 FI FI912315A patent/FI97807C/fi active
- 1991-05-13 ES ES9101157A patent/ES2033574B1/es not_active Expired - Fee Related
- 1991-05-13 DK DK088991A patent/DK88991A/da not_active Application Discontinuation
- 1991-05-13 MA MA22424A patent/MA22154A1/fr unknown
- 1991-05-13 NO NO911852A patent/NO180308C/no not_active IP Right Cessation
- 1991-05-13 SE SE9101431A patent/SE510808C2/sv not_active IP Right Cessation
- 1991-05-13 IE IE162891A patent/IE65891B1/en not_active IP Right Cessation
- 1991-05-13 BE BE9100441A patent/BE1007016A3/fr not_active IP Right Cessation
- 1991-05-14 DE DE4115681A patent/DE4115681C2/de not_active Expired - Lifetime
- 1991-05-14 FR FR9105766A patent/FR2661919B1/fr not_active Expired - Lifetime
- 1991-05-14 OA OA59998A patent/OA09352A/xx unknown
- 1991-05-14 PT PT97657A patent/PT97657B/pt not_active IP Right Cessation
- 1991-05-14 LU LU87935A patent/LU87935A1/fr unknown
- 1991-05-14 JP JP3109203A patent/JPH05117277A/ja active Pending
- 1991-07-09 TW TW080105317A patent/TW226998B/zh active
-
1993
- 1993-12-02 HK HK1319/93A patent/HK131993A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR247762A1 (es) | Un metodo para la preparacion de derivados de furo /3, 4-c/piridina en forma no-racemica | |
DE69100079D1 (de) | Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
PE31691A1 (es) | Procedimiento para la preparacion de nuevos compuestos fungicidas | |
AR241161A2 (es) | "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida" | |
PE20030131A1 (es) | Derivados de 6-fenildihidropirrolpirimidindiona | |
AU3158093A (en) | Novel phosphono-succinic acid derivatives, process for producing them and medicaments containing these compounds | |
KR960701878A (ko) | 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents) | |
BG94282A (bg) | 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они | |
KR910700253A (ko) | N_6-치환-9-메틸아데닌: 신규한 부류의 아데노신 수용체 길항질 | |
KR850002269A (ko) | 피리도인돌 유도체의 제조방법 | |
KR920006360A (ko) | 스쿠알렌 합성효소 억제제 | |
DE3684225D1 (de) | Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen. | |
DE3684235D1 (de) | Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen. | |
ATE27956T1 (de) | Cephalosporinverbindungen und verfahren zu ihrer herstellung. | |
DE3376421D1 (en) | Analgesia-effecting 5-hydroxytryptophan derivatives | |
ES8506652A1 (es) | Un metodo de preparar dihidrobenzopirrolbenzodiazepinas | |
PT87716A (pt) | Process for preparing cycloalkylamides of (8-beta)-1-alkyl-6-(substituted) ergolines | |
ATE31921T1 (de) | Amidine, verfahren zu ihrer herstellung und deren anwendung in der therapie. | |
DK136987D0 (da) | Selektive alfa-adrenerge receptorantagonister, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
ES2143630T3 (es) | Derivados azabicicloalquilos de imidazo(1,5-a)indol-3-ona utilizados como antagonistas de 5ht3. | |
ATE188700T1 (de) | Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung | |
PE86698A1 (es) | Derivados de indolina | |
CA2273894A1 (en) | Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use | |
KR890013015A (ko) | 복소환 화합물 및 항궤양제 | |
ES514634A0 (es) | "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina". |